Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019
Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acut...
Saved in:
Published in | The Journal of infectious diseases Vol. 223; no. 11; pp. 1842 - 1854 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background
Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear.
Methods
We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases.
Results
Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection.
Conclusions
In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses.
We provide an atlas of lung immunopathology of fatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, revealing unexpected broad cell tropism and infection of parenchymal, endothelial, and immune cells by SARS-CoV-2, which are associated with massive tissue damage and thromboemboli. |
---|---|
AbstractList | Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases. Results Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection. Conclusions In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses. Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear.BACKGROUNDCoronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear.We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases.METHODSWe performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases.Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection.RESULTSLung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection.In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses.CONCLUSIONSIn fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses. Abstract Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and thromboembolism. The mechanisms mediating these processes remain unclear. Methods We performed multicolor staining for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins and lineage markers to define viral tropism and lung pathobiology in 5 autopsy cases. Results Lung parenchyma showed severe DAD with thromboemboli. Viral infection was found in an extensive range of cells including pneumocyte type II, ciliated, goblet, club-like, and endothelial cells. More than 90% of infiltrating immune cells were positive for viral proteins including macrophages, monocytes, neutrophils, natural killer (NK) cells, B cells, and T cells. Most but not all infected cells were angiotensin-converting enzyme 2 (ACE2) positive. The numbers of infected and ACE2-positive cells are associated with extensive tissue damage. Infected tissues exhibited high levels of inflammatory cells including macrophages, monocytes, neutrophils, and NK cells, and low levels of B cells but abundant T cells consisting of mainly T helper cells, few cytotoxic T cells, and no regulatory T cells. Robust interleukin-6 expression was present in most cells, with or without infection. Conclusions In fatal COVID-19 lungs, there are broad SARS-CoV-2 cell tropisms, extensive infiltrated innate immune cells, and activation and depletion of adaptive immune cells, contributing to severe tissue damage, thromboemboli, excess inflammation, and compromised immune responses. We provide an atlas of lung immunopathology of fatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, revealing unexpected broad cell tropism and infection of parenchymal, endothelial, and immune cells by SARS-CoV-2, which are associated with massive tissue damage and thromboemboli. |
Author | Fowkes, Mary Ramos da Silva, Suzane Meng, Wen Green, Anthony Cordon-Cardo, Carlos Ju, Enguo Gao, Shou-Jiang Paniz Mondolfi, Alberto E Guo, Haitao Grimes, Zachary Dacic, Sanja Bryce, Clare Sordillo, Emilia M |
Author_xml | – sequence: 1 givenname: Suzane surname: Ramos da Silva fullname: Ramos da Silva, Suzane organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA – sequence: 2 givenname: Enguo surname: Ju fullname: Ju, Enguo organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA – sequence: 3 givenname: Wen surname: Meng fullname: Meng, Wen organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA – sequence: 4 givenname: Alberto E surname: Paniz Mondolfi fullname: Paniz Mondolfi, Alberto E organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 5 givenname: Sanja surname: Dacic fullname: Dacic, Sanja organization: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA – sequence: 6 givenname: Anthony surname: Green fullname: Green, Anthony organization: Tissue and Research Pathology Core, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA – sequence: 7 givenname: Clare surname: Bryce fullname: Bryce, Clare organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 8 givenname: Zachary surname: Grimes fullname: Grimes, Zachary organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 9 givenname: Mary surname: Fowkes fullname: Fowkes, Mary organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 10 givenname: Emilia M surname: Sordillo fullname: Sordillo, Emilia M organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 11 givenname: Carlos surname: Cordon-Cardo fullname: Cordon-Cardo, Carlos organization: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 12 givenname: Haitao surname: Guo fullname: Guo, Haitao organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA – sequence: 13 givenname: Shou-Jiang orcidid: 0000-0001-6194-1742 surname: Gao fullname: Gao, Shou-Jiang email: gaos8@upmc.edu organization: Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA |
BookMark | eNqFkU1rGzEQhkVxILaTa86CXtrDxvrYD-uYOnUSMAQS57zMamdTmV1pK2kD_gv91VVxLg2UnubyPO_M8C7IzDqLhFxxds2Zkitju9aE1cFAw1Xxicx5IausLLmckTljQmR8rdQ5WYRwYIzlsqzm5Nc376Clz_iGHumNniLSJwyj8RCdP9Lno229G5BunHcW3oyfAhV0g31P996NJgwUbEsfhmGyboT4w_Xu9UiNpbvJvtK9CWHCQLcphG4hQv9X0q0JCAGpYFxdkLMO-oCX73NJXrbf95v7bPd497C52WVaVnnMhKrKNldYYKFlyaRuO960VSeaEgRDzUHCWvFKKam1akpdNRIZNlAUyVKtXJIvp9zRu5_ptlgPJuj0EFh0U6hFwbnIJVfrhH7-gB7c5G26LlG54oKpQibq-kRp70Lw2NWjNwP4Y81Z_aea-lRN_V5NEvIPgjYRonE2ejD9v7WvJ81N4_9W_AZ346gM |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_968981 crossref_primary_10_1371_journal_pbio_3001959 crossref_primary_10_1002_jmv_28636 crossref_primary_10_1128_mbio_03011_23 crossref_primary_10_3390_biomedicines10051002 crossref_primary_10_1002_jmv_28246 crossref_primary_10_1016_j_scib_2023_08_031 crossref_primary_10_3390_v15091920 crossref_primary_10_1002_jmv_28566 crossref_primary_10_2139_ssrn_3941802 crossref_primary_10_1016_j_virol_2022_01_011 crossref_primary_10_1172_jci_insight_158126 crossref_primary_10_1016_S2213_2600_21_00408_2 crossref_primary_10_23736_S0031_0808_21_04595_X crossref_primary_10_1186_s12985_024_02597_3 crossref_primary_10_3389_fmed_2021_637642 crossref_primary_10_1360_SSV_2021_0294 crossref_primary_10_1172_JCI148036 crossref_primary_10_1002_jmv_27244 crossref_primary_10_1111_jop_13621 crossref_primary_10_3390_vaccines9101074 crossref_primary_10_1002_jmv_28437 crossref_primary_10_1002_jmv_29009 crossref_primary_10_3389_fimmu_2022_1050478 crossref_primary_10_1002_jmv_28032 crossref_primary_10_1002_jmv_28075 |
Cites_doi | 10.1016/j.cell.2020.04.035 10.1038/s41591-020-0901-9 10.15252/emmm.202012421 10.1093/cid/ciaa449 10.1002/jmv.25801 10.1016/j.autrev.2020.102567 10.1016/S2213-2600(20)30076-X 10.1056/NEJMoa2015432 10.1038/s41379-020-0595-z 10.1080/22221751.2020.1770129 10.1038/s41379-020-00661-1 10.1016/j.cell.2020.05.042 10.1016/S2213-2600(20)30243-5 10.1038/s41587-020-0602-4 10.1093/cid/ciaa248 10.1016/j.clim.2020.108516 10.1002/jmv.26139 10.1016/j.mehy.2020.110053 10.1038/nature03712 10.1016/j.csbj.2021.01.042 10.1002/jmv.26119 10.1016/j.cell.2020.05.006 10.1038/s41588-020-00731-9 10.1038/s41586-020-2012-7 10.1172/JCI140491 10.1016/j.chest.2020.09.259 10.1038/s41467-020-17292-4 10.1038/s41374-020-0464-x 10.1038/s41392-020-00355-9 10.1182/blood.2020007008 10.1038/s41577-020-0317-2 10.1038/s41586-020-2922-4 10.1016/S2213-2600(20)30193-4 10.1002/JLB.3COVR0520-272R 10.1128/CMR.00090-16 10.1002/jmv.25948 10.1016/j.celrep.2020.108175 10.3201/eid2609.202095 10.1111/joim.13162 10.1016/j.ebiom.2020.102833 |
ContentType | Journal Article |
Copyright | The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 – notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. |
DBID | AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.1093/infdis/jiab195 |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1537-6613 |
EndPage | 1854 |
ExternalDocumentID | 10_1093_infdis_jiab195 10.1093/infdis/jiab195 |
GroupedDBID | --- -DZ -~X ..I .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 123 1KJ 1TH 29K 2AX 2WC 36B 3O- 4.4 41~ 48X 53G 5GY 5RE 5VS 5WD 70D 85S AABZA AACGO AACZT AAHBH AAHTB AAJKP AAJQQ AAMVS AANCE AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYOK ABBHK ABDFA ABDPE ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPEJ ABPLY ABPPZ ABPQP ABPTD ABQLI ABQNK ABSMQ ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACFRR ACGFO ACGFS ACGOD ACHIC ACPQN ACPRK ACUFI ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFQV AFFZL AFHKK AFIYH AFOFC AFQQW AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS AQVQM ATGXG AVNTJ AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BR6 BTRTY BVRKM BZKNY C45 CDBKE CS3 CZ4 D-I DAKXR DCCCD DIK DILTD DU5 D~K EBS ECGQY EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HQ3 HTVGU HW0 HZ~ IH2 IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B LSO LU7 M49 MBLQV MHKGH MJL ML0 MVM N4W N9A NEJ NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P0- P2P PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 VH1 W2D W8F WH7 X7H X7M Y6R YAYTL YKOAZ YXANX ZE2 ZGI ZKG ZXP ~91 AAYXX AGORE AHGBF AJBYB CITATION K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c374t-2976d49e5e5c3603cdf1bd7f2b6a20ec1a3a8917993cc9b6c7b3e0eba5549e9d3 |
ISSN | 0022-1899 1537-6613 |
IngestDate | Thu Jul 10 16:49:41 EDT 2025 Mon Jun 30 10:37:04 EDT 2025 Tue Jul 01 01:31:28 EDT 2025 Thu Apr 24 22:56:46 EDT 2025 Wed Apr 02 07:04:31 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | COVID-19 thromboemboli SARS-CoV-2 diffuse alveolar damage inflammation immunofluorescence assay immunosuppression immunohistochemistry IL-6 cell tropism |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c374t-2976d49e5e5c3603cdf1bd7f2b6a20ec1a3a8917993cc9b6c7b3e0eba5549e9d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6194-1742 |
OpenAccessLink | https://academic.oup.com/jid/article-pdf/223/11/1842/38488329/jiab195.pdf |
PQID | 2549120953 |
PQPubID | 41591 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2511243198 proquest_journals_2549120953 crossref_primary_10_1093_infdis_jiab195 crossref_citationtrail_10_1093_infdis_jiab195 oup_primary_10_1093_infdis_jiab195 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-06-01 |
PublicationDateYYYYMMDD | 2021-06-01 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: Oxford |
PublicationTitle | The Journal of infectious diseases |
PublicationYear | 2021 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Bost (2021070809093717000_CIT0008) 2020; 181 Best Rocha (2021070809093717000_CIT0013) 2020; 100 Wang (2021070809093717000_CIT0017) 2020; 108 Aziz (2021070809093717000_CIT0020) 2020; 92 Borczuk (2021070809093717000_CIT0028) 2020; 33 Travaglini (2021070809093717000_CIT0005) 2020; 587 Ackermann (2021070809093717000_CIT0026) 2020; 383 Qin (2021070809093717000_CIT0039) 2020; 71 Xu (2021070809093717000_CIT0003) 2020; 8 Jamilloux (2021070809093717000_CIT0023) 2020; 19 Hariri (2021070809093717000_CIT0025) 2021; 159 Liao (2021070809093717000_CIT0010) 2020; 26 Liu (2021070809093717000_CIT0040) 2020; 81 Liu (2021070809093717000_CIT0019) 2020; 12 Russell (2021070809093717000_CIT0036) 2017; 30 Carnevale (2021070809093717000_CIT0029) 2021; 93 Han (2021070809093717000_CIT0016) 2020; 9 Eimer (2021070809093717000_CIT0021) 2021; 289 Zhou (2021070809093717000_CIT0001) 2020; 579 Schaefer (2021070809093717000_CIT0015) 2020; 33 Travaglini (2021070809093717000_CIT0033) 2020; 587 Chen (2021070809093717000_CIT0018) 2020; 71 Park (2021070809093717000_CIT0038) 2020; 20 Qin (2021070809093717000_CIT0006) 2021; 19 Scherger (2021070809093717000_CIT0024) 2020; 144 Martines (2021070809093717000_CIT0035) 2020; 26 Files (2021070809093717000_CIT0043) 2021; 131 Onabajo (2021070809093717000_CIT0012) 2020; 52 Middleton (2021070809093717000_CIT0037) 2020; 136 Zhuang (2021070809093717000_CIT0011) 2020; 92 Fox (2021070809093717000_CIT0027) 2020; 8 Bryce (2021070809093717000_CIT0002) 2020 Imai (2021070809093717000_CIT0031) 2005; 436 Chua (2021070809093717000_CIT0009) 2020; 38 Luo (2021070809093717000_CIT0022) 2020; 92 De Biasi (2021070809093717000_CIT0041) 2020; 11 Leng (2021070809093717000_CIT0030) 2020; 5 Singh (2021070809093717000_CIT0004) 2020; 32 Ziegler (2021070809093717000_CIT0007) 2020; 181 Jiang (2021070809093717000_CIT0042) 2020; 218 Wang (2021070809093717000_CIT0034) 2020; 57 Hou (2021070809093717000_CIT0032) 2020; 182 Hui (2021070809093717000_CIT0014) 2020; 8 |
References_xml | – volume: 181 start-page: 1016 year: 2020 ident: 2021070809093717000_CIT0007 article-title: SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues publication-title: Cell doi: 10.1016/j.cell.2020.04.035 – volume: 26 start-page: 842 year: 2020 ident: 2021070809093717000_CIT0010 article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 publication-title: Nat Med doi: 10.1038/s41591-020-0901-9 – volume: 12 start-page: e12421 year: 2020 ident: 2021070809093717000_CIT0019 article-title: The role of interleukin-6 in monitoring severe case of coronavirus disease 2019 publication-title: EMBO Mol Med doi: 10.15252/emmm.202012421 – volume: 71 start-page: 1937 year: 2020 ident: 2021070809093717000_CIT0018 article-title: Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019 publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa449 – volume: 92 start-page: 814 year: 2020 ident: 2021070809093717000_CIT0022 article-title: Tocilizumab treatment in COVID-19: a single center experience publication-title: J Med Virol doi: 10.1002/jmv.25801 – volume: 19 start-page: 102567 year: 2020 ident: 2021070809093717000_CIT0023 article-title: Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2020.102567 – volume: 8 start-page: 420 year: 2020 ident: 2021070809093717000_CIT0003 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30076-X – volume: 383 start-page: 120 year: 2020 ident: 2021070809093717000_CIT0026 article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2015432 – volume: 33 start-page: 2104 year: 2020 ident: 2021070809093717000_CIT0015 article-title: In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19 publication-title: Mod Pathol doi: 10.1038/s41379-020-0595-z – volume: 9 start-page: 1123 year: 2020 ident: 2021070809093717000_CIT0016 article-title: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1770129 – volume: 33 start-page: 2156 year: 2020 ident: 2021070809093717000_CIT0028 article-title: COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City publication-title: Mod Pathol doi: 10.1038/s41379-020-00661-1 – volume: 182 start-page: 429 year: 2020 ident: 2021070809093717000_CIT0032 article-title: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract publication-title: Cell doi: 10.1016/j.cell.2020.05.042 – volume: 8 start-page: 681 year: 2020 ident: 2021070809093717000_CIT0027 article-title: Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30243-5 – volume: 38 start-page: 970 year: 2020 ident: 2021070809093717000_CIT0009 article-title: COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0602-4 – volume: 71 start-page: 762 year: 2020 ident: 2021070809093717000_CIT0039 article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa248 – volume: 218 start-page: 108516 year: 2020 ident: 2021070809093717000_CIT0042 article-title: COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential publication-title: Clin Immunol doi: 10.1016/j.clim.2020.108516 – volume: 92 start-page: 2693 year: 2020 ident: 2021070809093717000_CIT0011 article-title: Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection publication-title: J Med Virol doi: 10.1002/jmv.26139 – volume: 144 start-page: 110053 year: 2020 ident: 2021070809093717000_CIT0024 article-title: Rethinking interleukin-6 blockade for treatment of COVID-19 publication-title: Med Hypotheses doi: 10.1016/j.mehy.2020.110053 – volume: 436 start-page: 112 year: 2005 ident: 2021070809093717000_CIT0031 article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure publication-title: Nature doi: 10.1038/nature03712 – volume: 81 start-page: 318 year: 2020 ident: 2021070809093717000_CIT0040 article-title: Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19 publication-title: J Infect – volume: 19 start-page: 1163 year: 2021 ident: 2021070809093717000_CIT0006 article-title: 3044 Cases reveal important prognosis signatures of COVID-19 patients publication-title: Comput Struct Biotechnol J doi: 10.1016/j.csbj.2021.01.042 – volume: 93 start-page: 61 year: 2021 ident: 2021070809093717000_CIT0029 article-title: Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea publication-title: J Med Virol doi: 10.1002/jmv.26119 – volume: 181 start-page: 1475 year: 2020 ident: 2021070809093717000_CIT0008 article-title: Host-viral infection maps reveal signatures of severe COVID-19 patients publication-title: Cell doi: 10.1016/j.cell.2020.05.006 – volume: 52 start-page: 1283 year: 2020 ident: 2021070809093717000_CIT0012 article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor publication-title: Nat Genet doi: 10.1038/s41588-020-00731-9 – volume: 579 start-page: 270 year: 2020 ident: 2021070809093717000_CIT0001 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 – volume: 131 start-page: 140491 year: 2021 ident: 2021070809093717000_CIT0043 article-title: Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection publication-title: J Clin Invest doi: 10.1172/JCI140491 – volume: 159 start-page: 73 year: 2021 ident: 2021070809093717000_CIT0025 article-title: Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory syndrome and H1N1 influenza: a systematic review publication-title: Chest doi: 10.1016/j.chest.2020.09.259 – volume: 11 start-page: 3434 year: 2020 ident: 2021070809093717000_CIT0041 article-title: Marked T cell activation, senescence, exhaustion and skewing towards Th17 in patients with COVID-19 pneumonia publication-title: Nat Commun doi: 10.1038/s41467-020-17292-4 – volume: 100 start-page: 1485 year: 2020 ident: 2021070809093717000_CIT0013 article-title: Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents publication-title: Lab Invest doi: 10.1038/s41374-020-0464-x – volume: 5 start-page: 240 year: 2020 ident: 2021070809093717000_CIT0030 article-title: Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-00355-9 – volume: 136 start-page: 1169 year: 2020 ident: 2021070809093717000_CIT0037 article-title: Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome publication-title: Blood doi: 10.1182/blood.2020007008 – year: 2020 ident: 2021070809093717000_CIT0002 article-title: Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience publication-title: medRxiv [Preprint] – volume: 20 start-page: 351 year: 2020 ident: 2021070809093717000_CIT0038 article-title: Macrophages: a Trojan horse in COVID-19? publication-title: Nat Rev Immunol doi: 10.1038/s41577-020-0317-2 – volume: 587 start-page: 619 year: 2020 ident: 2021070809093717000_CIT0033 article-title: A molecular cell atlas of the human lung from single cell RNA sequencing publication-title: Nature doi: 10.1038/s41586-020-2922-4 – volume: 8 start-page: 687 year: 2020 ident: 2021070809093717000_CIT0014 article-title: Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30193-4 – volume: 587 start-page: 619 year: 2020 ident: 2021070809093717000_CIT0005 article-title: A molecular cell atlas of the human lung from single-cell RNA sequencing publication-title: Nature doi: 10.1038/s41586-020-2922-4 – volume: 108 start-page: 17 year: 2020 ident: 2021070809093717000_CIT0017 article-title: Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts publication-title: J Leukoc Biol doi: 10.1002/JLB.3COVR0520-272R – volume: 30 start-page: 481 year: 2017 ident: 2021070809093717000_CIT0036 article-title: The human immune response to respiratory syncytial virus infection publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00090-16 – volume: 92 start-page: 2283 year: 2020 ident: 2021070809093717000_CIT0020 article-title: Elevated interleukin-6 and severe COVID-19: a meta-analysis publication-title: J Med Virol doi: 10.1002/jmv.25948 – volume: 32 start-page: 108175 year: 2020 ident: 2021070809093717000_CIT0004 article-title: A single-cell RNA expression map of human coronavirus entry factors publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108175 – volume: 26 start-page: 2005 year: 2020 ident: 2021070809093717000_CIT0035 article-title: Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States publication-title: Emerg Infect Dis doi: 10.3201/eid2609.202095 – volume: 289 start-page: 434 year: 2021 ident: 2021070809093717000_CIT0021 article-title: Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study publication-title: J Intern Med doi: 10.1111/joim.13162 – volume: 57 start-page: 102833 year: 2020 ident: 2021070809093717000_CIT0034 article-title: Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102833 |
SSID | ssj0004367 |
Score | 2.4994519 |
Snippet | Abstract
Background
Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive... Background Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation,... Coronavirus disease 2019 (COVID-19) patients manifest with pulmonary symptoms reflected by diffuse alveolar damage (DAD), excessive inflammation, and... |
SourceID | proquest crossref oup |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1842 |
SubjectTerms | ACE2 Alveoli Angiotensin Angiotensin-converting enzyme 2 Autopsy Cell activation Coronaviruses COVID-19 Cytotoxicity Endothelial cells Helper cells Immunoregulation Inflammation Interleukin 6 Leukocytes (neutrophilic) Lymphocytes Lymphocytes B Lymphocytes T Macrophages Monocytes Natural killer cells Neutrophils Parenchyma Peptidyl-dipeptidase A Severe acute respiratory syndrome coronavirus 2 Thromboembolism Tropism Viral infections |
Title | Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019 |
URI | https://www.proquest.com/docview/2549120953 https://www.proquest.com/docview/2511243198 |
Volume | 223 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKEIgXBANEYSCDkHiIsiV2mjSP00a1jT9CrBN7ixzbQUFdMnXtJPYR-I58F-5iJ3GnDQYvUeU67p_7-XLnu98dIW8SkYB7U2hf6ET4URoofxzp0EfGj9Cp4MxkW3yK946ig-PR8WDwy8laWi7yTXlxJa_kf6QKYyBXZMn-g2S7RWEAXoN84QoShuuNZAw-tAB7UcMX1962xJD_Fyd0fmirEcCmn4PBfV7Ol2ce83bwuG46r0_b_hj7yBGpsTexKchUVt4H0AEgx6Y1Hxi39Yk3adqMuCvtmtiOBw_31LVxe7aZLUhh0r3gDhsN6tPrxUkNo8I7LGfnwiQJXYg-0H-wbFR19W1Zd8DQRjl97Slsn5FMispJ1bOiNKwdTBevLcvCnmkwJ_fqT1xJV4-DCx2OTWulTd2q7sQHa4O7up0ZMnML4tBR1eDaMuexD3ZLdOUjxZTbgiGFRR8m30uRh6Yv6KVC3ddPvkVuM_BisMHG7v77nrbL46QtZo8_pqspyrfMClv2_hWbaYWH2RoOjTU0fUDuW_HSbYPJh2Sgq3VyxzQ2_bFO7n60KRuPyM8GpNSAlDYgpQ5IaQtS6kCLMoogpRakFEBKL4GUlhVFkFILUoogpQ1IV1ayIKUI0sfkaPJuurPn2wYgvuRJtPAZ2MoqSvVIjySPAy5VEeYqKVgeCxZoGQouxinWNORSpnksk5zrQOcCbORUp4o_IWtVXemnhOpCCiEjcG5UHCUqETJVRRHAarA0Z-GQ-O1fnElbHR-btMwyk6XBMyOSzIpkSN52809NXZhrZ74Gif110kYr0MwqmLMMz26Q2j7iQ_KqexvUP8b0YDPCxs3whICBE5COn93kc56Te_1-2yBri_lSvwCrepG_bLD5GzJ91yE |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Broad+Severe+Acute+Respiratory+Syndrome+Coronavirus+2+Cell+Tropism+and+Immunopathology+in+Lung+Tissues+From+Fatal+Coronavirus+Disease+2019&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Ramos+da+Silva%2C+Suzane&rft.au=Ju%2C+Enguo&rft.au=Meng%2C+Wen&rft.au=Paniz+Mondolfi%2C+Alberto+E&rft.date=2021-06-01&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=223&rft.issue=11&rft.spage=1842&rft.epage=1854&rft_id=info:doi/10.1093%2Finfdis%2Fjiab195&rft.externalDocID=10.1093%2Finfdis%2Fjiab195 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon |